Health Policy Weekly Archive

US Capitol building

January 21, 2022

Money is honey but drugs can improve lives: Insights on Rx spending

January 14, 2022

And just like that… More barriers to treatment for Alzheimer’s patients

January 7, 2022

Getting back on the horse: Proposed MA/Part D rule

December 17, 2021

Not on the naughty list: Califf confirmation hearing

December 10, 2021

Time keeps on slippin’, slippin’, slippin’ into the future for the Build Back Better Act (BBBA)

December 3, 2021

Spending bill funds government into February but does not forestall Medicare sequester cuts

November 19, 2021

Cluck is ticking on the Build Back Better Act

November 12, 2021

Doesn’t everyone read legislative text cozy near a fire pit? Status of the Build Back Better Act

November 5, 2021

Just when I thought I was out, they pull me back in: Drug pricing provisions

October 29, 2021

Abra cadabra. Lobbyists make drug pricing proposals disappear

October 22, 2021

CMMI: Strategic approach more sophisticated than throwing spaghetti at a wall

October 15, 2021

Stars in eyes as open enrollment starts

October 8, 2021

Not quite D-feet but clock ticking

October 1, 2021

Like everyone, our best guess uses fortune paper origami. Yes, no, maybe for Congress to pass a multi-trillion dollar reconciliation bill

September 24, 2021

Foot off the gas: Stalling expedited pathway to coverage

September 17, 2021

If the devil is in the details, this plan is an angel: Administration releases drug pricing proposals

August 27, 2021

A quick update and original research before we take an end-of-summer break

August 20, 2021

It’s like when you hear Déjà vu on the radio for the 20th time minus the strawberry ice cream. Drug pricing reform

August 6, 2021

Bats rely on insects and nectar; hospitals rely on IPPS payment increases

July 30, 2021

Time to discus: FDA approves first interchangeable

July 23, 2021

OPPS, ASC me again? I was distracted with Olympics coverage

July 16, 2021

Anything is popsicle this summer. EO includes drug pricing and importation

July 2, 2021

You can almost feel the finger wag: Biden pushes ahead on ACA changes

June 25, 2021

Writing with a dull pencil is pointless: New drug pricing principles

June 18, 2021

Did Miss Cleo predict this one? ACA upheld

June 11, 2021

Is the FDA advisory committee a potted plant?

June 4, 2021

President Biden’s budget proposal for FY 2022 is “DOA”

May 21, 2021

PIVOT: HRSA responds to contract pharmacy arrangements under 340B

May 14, 2021

It's a light week in health policy news

May 7, 2021

A peony saved is a peony earned. March has lions and lambs, April has showers, May brings drug pricing talks

April 30, 2021

Baby, one more time: Third stimulus package

April 23, 2021

Who run the world? Girls. HHS nomination update

April 16, 2021

Like the trees, re-leafed about nomination hearing

April 9, 2021

In anticipation of some special sauce, (Big) MAC—hold the claim, please

March 26, 2021

A percent not cut is a percent earned

March 19, 2021

Slaughter-ing pharma M&A?

March 12, 2021

The ARP of the deal: COVID relief package signed

March 5, 2021

No cost and—bonus—you get an experience that makes you unsure whether to laugh or cry

February 26, 2021

Our quiet days might be over, a new Becerra-iff in town

February 19, 2021

Judge tells hospitals to slow their roll with the 340B lawsuit

February 12, 2021

Blowing the lid off Medicaid rebates

February 5, 2021

Rules, rules, go away, come again another day


January 29, 2021

Anyone else picture the Mutombo finger wag? EO reverses previous policy and looks to expand coverage

January 22, 2021

Changing of the guard: new administration, new players

January 15, 2021

There’s always a critic: legal challenge filed against rebate rule

December 18, 2020

December 4, 2020

Health Policy Weekly

Better late than never? Regulatory sprint continues. 2021 PFS and OPPS final rules